Shopping Cart
Remove All
Your shopping cart is currently empty
Nerandomilast (BI 1015550) is an orally active PDE4B inhibitor with IC50 of 7.2 nM. BI 1015550 has potential applications in inflammation, allergic diseases, pulmonary fibrosis and chronic obstructive pulmonary disease (COPD) with a good safety profile.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $59 | In Stock | In Stock | |
| 5 mg | $127 | In Stock | In Stock | |
| 10 mg | $197 | In Stock | In Stock | |
| 25 mg | $396 | - | In Stock | |
| 50 mg | $589 | - | In Stock | |
| 100 mg | $843 | - | In Stock | |
| 200 mg | $1,160 | - | In Stock |
| Description | Nerandomilast (BI 1015550) is an orally active PDE4B inhibitor with IC50 of 7.2 nM. BI 1015550 has potential applications in inflammation, allergic diseases, pulmonary fibrosis and chronic obstructive pulmonary disease (COPD) with a good safety profile. |
| Targets&IC50 | PDE4B:7.2 nM |
| In vivo | METHODS: Rats were treated with Nerandomilast (BI 1015550) (0.01, 0.1, 1, 3 mg/kg, oral) to study its effect on LPS-stimulated TNF-α release in rat whole blood.
RESULTS Nerandomilast (BI 1015550) at a dose of 3 mg/kg inhibited 93% of TNF-α release. The final experimental result showed that the dose of Nerandomilast (BI 1015550) that caused half-maximal inhibition (ED50) of LPS-induced TNF-α release was 0.04 mg/kg. [1] |
| Synonyms | BI 1015550 |
| Molecular Weight | 448.97 |
| Formula | C20H25ClN6O2S |
| Cas No. | 1423719-30-5 |
| Smiles | N(C1=C2C(=NC(=N1)N3CCC(CC3)C=4N=CC(Cl)=CN4)CCS2=O)C5(CO)CCC5 |
| Relative Density. | no data available |
| Color | White |
| Appearance | Solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||
| Solubility Information | DMSO: 4.49 mg/mL (10 mM), Sonication is recommended. | ||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||
DMSO
| |||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.